Analysis of epigenomic abnormalities in Merkel cell carcinoma
Project/Area Number |
17K15644
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Human pathology
|
Research Institution | Tottori University |
Principal Investigator |
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | MCPyV / SWI/SNF複合体 / H3K27me3 / Notch / エピゲノム / メルケル細胞癌 / メルケル細胞ポリオーマウイルス / 遺伝子病理診断学 |
Outline of Final Research Achievements |
Merkel cell carcinoma (MCC) is a malignant neuroendocrine skin tumor that occurs most often in elderly patients. Approximately 80% of MCCs harbor Merkel cell polyomavirus (MCPyV), thought to be a carcinogenic agent. In this study, modification of H3K27me3 was significantly lower in MCPyV-negative MCCs than in MCPyV-positive MCCs.
|
Academic Significance and Societal Importance of the Research Achievements |
遺伝子発現やクロマチン状態は、ヒストン修飾を始めとしたエピジェネティクスな制御を受ける。H3K27me3の修飾状態がMCPyV陽性MCCとMCPyV陰性MCCで異なることからMCPyV陽性MCCとMCPyV陰性MCCでの遺伝子発現の差異の原因の一つである可能性が示唆され、治療法の開発へとつながる研究基盤となることが期待される。
|
Report
(4 results)
Research Products
(6 results)